T. Rowe Price Associates’s QCR Holdings QCRH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.29M Buy
61,862
+7,300
+13% +$636K ﹤0.01% 1402
2025
Q4
$4.55M Buy
54,562
+3,436
+7% +$270K ﹤0.01% 1418
2025
Q3
$3.87M Buy
51,126
+36,439
+248% +$2.74M ﹤0.01% 1472
2025
Q2
$998K Buy
14,687
+2,904
+25% +$194K ﹤0.01% 1985
2025
Q1
$841K Buy
11,783
+1,110
+10% +$84.6K ﹤0.01% 2044
2024
Q4
$861K Buy
10,673
+1,222
+13% +$103K ﹤0.01% 2032
2024
Q3
$700K Buy
9,451
+4,278
+83% +$304K ﹤0.01% 2114
2024
Q2
$311K Buy
5,173
+460
+10% +$26.3K ﹤0.01% 2396
2024
Q1
$287K Buy
4,713
+539
+13% +$30.9K ﹤0.01% 2452
2023
Q4
$244K Buy
+4,174
New +$216K ﹤0.01% 2463
2023
Q2
Sell
-17,247
Closed -$758K 2933
2023
Q1
$758K Buy
17,247
+39
+0.2% +$1.94K ﹤0.01% 1915
2022
Q4
$855K Buy
17,208
+94
+0.5% +$4.84K ﹤0.01% 1852
2022
Q3
$873K Buy
17,114
+968
+6% +$54.1K ﹤0.01% 1827
2022
Q2
$872K Buy
16,146
+101
+0.6% +$5.51K ﹤0.01% 1964
2022
Q1
$908K Buy
+16,045
New +$916K ﹤0.01% 2053

Other funds holding QCRH

T. Rowe Price Associates's QCRH Position: Q1 2026 in Review

T. Rowe Price Associates increased its QCR Holdings (QCRH) stake by 13% in Q1 2026, buying an estimated $636K and bringing the position to 61,862 shares worth $5.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1402.

T. Rowe Price Associates first reported a position in QCRH in Q1 2022 and has held it in 15 quarters since. 223 funds tracked by Wall St. Rank hold QCRH as of Q1 2026.

  • T. Rowe Price Associates held 61,862 shares of QCR Holdings worth $5.29M as of Q1 2026.
  • T. Rowe Price Associates bought 7,300 QCR Holdings shares in Q1 2026, an estimated $636K.
  • QCR Holdings made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1402 holding.
  • T. Rowe Price Associates first reported a position in QCR Holdings in Q1 2022 and has held it in 15 quarters since.
  • 223 funds tracked by Wall St. Rank held QCR Holdings as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.